Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 3/2008

01.09.2008

Early diagnosis and prevention of diabetes in developing countries

verfasst von: Ramachandran Ambady, Snehalatha Chamukuttan

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Type 2 diabetes has an insidious onset with a long latent period of dysglycaemia. By the time the diagnosis of diabetes is made, diabetes-related tissue damage occurs in nearly half of the patients. Even after diagnosis, the glycaemic control is suboptimal in more than 50%, leading to the vascular complications. Evidences suggest that early detection of diabetes by appropriate screening methods, especially in subjects with high risk for diabetes will help to prevent or delay the vascular complications and thus reduce the clinical, social and economic burden of the disease. There are also evidences to show that intervention at the prediabetic stage is superior to diagnosis of diabetes.
Literatur
1.
Zurück zum Zitat Sicree R, Shaw J, Zimmet P. Chap 1.1. Prevalence and projections. In: Gan D, editor. Diabetes Atlas, World Diabetes Foundation. 3rd ed. Brussels, Belgium: International Diabetes Federation; 2006. p. 16–104. Sicree R, Shaw J, Zimmet P. Chap 1.1. Prevalence and projections. In: Gan D, editor. Diabetes Atlas, World Diabetes Foundation. 3rd ed. Brussels, Belgium: International Diabetes Federation; 2006. p. 16–104.
2.
Zurück zum Zitat Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1–27.PubMed Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1–27.PubMed
3.
Zurück zum Zitat Dowse GK, Zimmet PZ, Finch CF, Collins VR. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the thrifty genotype. Am J Epidemiol 1991;133:1093–104.PubMed Dowse GK, Zimmet PZ, Finch CF, Collins VR. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the thrifty genotype. Am J Epidemiol 1991;133:1093–104.PubMed
4.
Zurück zum Zitat Brown JB. Dorte Vistisen, Sicree R, Shaw J, Nichols G, Ping Z. Chap 5. The economic impacts of diabetes. In: Gan D, editor. Diabetes Atlas, 3rd edition. Brussels, Belgium: International Diabetes Federation; 2006. p. 237–65. Brown JB. Dorte Vistisen, Sicree R, Shaw J, Nichols G, Ping Z. Chap 5. The economic impacts of diabetes. In: Gan D, editor. Diabetes Atlas, 3rd edition. Brussels, Belgium: International Diabetes Federation; 2006. p. 237–65.
5.
Zurück zum Zitat Ramachandran A, Shobhana R, Snehalatha C, Christina A, Murugesan N, Vijay V, et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country. Diabetes Care 2007;30:252–6. doi:10.2337/dc06-0144.PubMedCrossRef Ramachandran A, Shobhana R, Snehalatha C, Christina A, Murugesan N, Vijay V, et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country. Diabetes Care 2007;30:252–6. doi:10.​2337/​dc06-0144.PubMedCrossRef
8.
Zurück zum Zitat American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27(Suppl1):S12–4. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27(Suppl1):S12–4.
9.
Zurück zum Zitat World Health Organization. Screening for type 2 diabetes. Geneva. 2003. World Health Organization. Screening for type 2 diabetes. Geneva. 2003.
10.
Zurück zum Zitat DECODE Study Group EDEG. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases? Diabetes Care 2003;26:688–96. doi:10.2337/diacare.26.3.688.CrossRef DECODE Study Group EDEG. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases? Diabetes Care 2003;26:688–96. doi:10.​2337/​diacare.​26.​3.​688.CrossRef
12.
Zurück zum Zitat Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost- effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000;24(Suppl 3):S6–11. doi:10.1038/sj/ijo/0801420.PubMed Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost- effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000;24(Suppl 3):S6–11. doi:10.​1038/​sj/​ijo/​0801420.PubMed
13.
Zurück zum Zitat Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diab/Metab Res and Rev 2000;16:164–71.CrossRef Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diab/Metab Res and Rev 2000;16:164–71.CrossRef
15.
Zurück zum Zitat Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–10. doi:10.1056/NEJMoa012578.PubMedCrossRef Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–10. doi:10.​1056/​NEJMoa012578.PubMedCrossRef
16.
Zurück zum Zitat Arslanian SA. Metabolic differences between Caucasian and African American children and the relationship of type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(Supp1):509–17.PubMed Arslanian SA. Metabolic differences between Caucasian and African American children and the relationship of type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(Supp1):509–17.PubMed
18.
Zurück zum Zitat Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keene H. Coronary heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373–6.PubMedCrossRef Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keene H. Coronary heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373–6.PubMedCrossRef
19.
Zurück zum Zitat Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. The 1997 American Diabetes Association and 1999 World Health Organisation criteria for hyperglycaemia in the diagnosis and predicting diabetes. Diabetes Care 2000;23:1108–12. doi:10.2337/diacare.23.8.1108.PubMedCrossRef Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. The 1997 American Diabetes Association and 1999 World Health Organisation criteria for hyperglycaemia in the diagnosis and predicting diabetes. Diabetes Care 2000;23:1108–12. doi:10.​2337/​diacare.​23.​8.​1108.PubMedCrossRef
20.
Zurück zum Zitat Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893–8. doi:10.1001/jama.263.21.2893.PubMedCrossRef Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893–8. doi:10.​1001/​jama.​263.​21.​2893.PubMedCrossRef
22.
Zurück zum Zitat Liao D, Shofer JB, Boyko EJ, Mc Neely MJ, leo Netti DL, Khan SE, Fujimoto WY. Abnormal glucose tolerance and increased risk for cardio vascular disease in Japanese Americans with normal fasting glucose. Diabetes Care 2001;24:39–44. doi:10.2337/diacare.24.1.39.PubMedCrossRef Liao D, Shofer JB, Boyko EJ, Mc Neely MJ, leo Netti DL, Khan SE, Fujimoto WY. Abnormal glucose tolerance and increased risk for cardio vascular disease in Japanese Americans with normal fasting glucose. Diabetes Care 2001;24:39–44. doi:10.​2337/​diacare.​24.​1.​39.PubMedCrossRef
23.
Zurück zum Zitat Snehaltha C, Mary S, Joshi VV, Ramachandran A. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors. Results of the Indian diabetes prevention programme. Diab Vasc Dis Res 2008;5:25–9. doi:10.3132/dvdr.2008.005.CrossRef Snehaltha C, Mary S, Joshi VV, Ramachandran A. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors. Results of the Indian diabetes prevention programme. Diab Vasc Dis Res 2008;5:25–9. doi:10.​3132/​dvdr.​2008.​005.CrossRef
27.
Zurück zum Zitat Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrin Metab. 2008. doi:10.1210/jc 2007-2174. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrin Metab. 2008. doi:10.​1210/​jc 2007-2174.
32.
Zurück zum Zitat Ramachandran A, Snehalatha C, Vijay V, Colagiuri S. Detecting undiagnosed Diabetes in Urban Asian Indians—role of opportunistic screening. JAPI 2004;52:545–6.PubMed Ramachandran A, Snehalatha C, Vijay V, Colagiuri S. Detecting undiagnosed Diabetes in Urban Asian Indians—role of opportunistic screening. JAPI 2004;52:545–6.PubMed
33.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86. doi:10.1056/NEJM199309303291401.CrossRef The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86. doi:10.​1056/​NEJM199309303291​401.CrossRef
34.
Zurück zum Zitat UK Prospective Diabetes Study Group. (UKPDS 38). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998;317:703–13. UK Prospective Diabetes Study Group. (UKPDS 38). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998;317:703–13.
35.
36.
Zurück zum Zitat Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17. doi:10.1016/0168-8227(95)01064-K.PubMedCrossRef Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17. doi:10.​1016/​0168-8227(95)01064-K.PubMedCrossRef
38.
Zurück zum Zitat International Diabetes Federation. Clinical Guidelines Task Force. Glucose control levels. In: Global guideline for type 2 diabetes. Brussels: IDF; 2005. p. 26–28. International Diabetes Federation. Clinical Guidelines Task Force. Glucose control levels. In: Global guideline for type 2 diabetes. Brussels: IDF; 2005. p. 26–28.
39.
40.
Zurück zum Zitat The Diabetes Control and Complications Trial/Epidemiology of diabetes interventions and complications (DCCT/EDIC) Research Group. Retinopathy and nephropathy in patients with Type I diabetes few years after a trial of intensive therapy. N Engl J Med 2000;343:381–9.CrossRef The Diabetes Control and Complications Trial/Epidemiology of diabetes interventions and complications (DCCT/EDIC) Research Group. Retinopathy and nephropathy in patients with Type I diabetes few years after a trial of intensive therapy. N Engl J Med 2000;343:381–9.CrossRef
44.
Zurück zum Zitat Liu K, Dyer AR, Thanh-Huyen VU, Pirzada A, Manheim LM, Manning WG, et al. One-hour postload plasma glucose in middle age and medicare expenditures in older age among nondiabetic men and women. Diabetes Care 2005;28:1057–62. doi:10.2337/diacare.28.5.1057.PubMedCrossRef Liu K, Dyer AR, Thanh-Huyen VU, Pirzada A, Manheim LM, Manning WG, et al. One-hour postload plasma glucose in middle age and medicare expenditures in older age among nondiabetic men and women. Diabetes Care 2005;28:1057–62. doi:10.​2337/​diacare.​28.​5.​1057.PubMedCrossRef
45.
Zurück zum Zitat Schneider H, Ehrhch M, Lischinski M, Schneider F. Bewirkte das flachendeckende Glukkosurie—Screening der 60er and 70er Jahre im Osten Deutschlands tatsachlich den erhofften Prognosevorteil furdie fruhzeititig entdeckten Diabetiker? Diabetes Stoffwechsel 1996;5:33–8. Schneider H, Ehrhch M, Lischinski M, Schneider F. Bewirkte das flachendeckende Glukkosurie—Screening der 60er and 70er Jahre im Osten Deutschlands tatsachlich den erhofften Prognosevorteil furdie fruhzeititig entdeckten Diabetiker? Diabetes Stoffwechsel 1996;5:33–8.
46.
Zurück zum Zitat Knowler WC, Barett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403. doi:10.1056/NEJMoa012512.PubMedCrossRef Knowler WC, Barett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403. doi:10.​1056/​NEJMoa012512.PubMedCrossRef
47.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilannie-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50. doi:10.1056/NEJM200105033441801.PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilannie-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50. doi:10.​1056/​NEJM200105033441​801.PubMedCrossRef
48.
Zurück zum Zitat Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997;20:537–44. doi:10.2337/diacare.20.4.537.PubMedCrossRef Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997;20:537–44. doi:10.​2337/​diacare.​20.​4.​537.PubMedCrossRef
49.
Zurück zum Zitat Ramachandran A, Snehalatha C, Mary S, Mukesh B, Baskar AD, Vijay V. The Indian Diabetes Prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–97. doi:10.1007/s00125-005-0097-z.PubMedCrossRef Ramachandran A, Snehalatha C, Mary S, Mukesh B, Baskar AD, Vijay V. The Indian Diabetes Prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–97. doi:10.​1007/​s00125-005-0097-z.PubMedCrossRef
50.
Zurück zum Zitat The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2000;28:888–94.CrossRef The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2000;28:888–94.CrossRef
51.
Zurück zum Zitat Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007;30:2548–52. doi:10.2337/dc07-0150.PubMedCrossRef Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007;30:2548–52. doi:10.​2337/​dc07-0150.PubMedCrossRef
53.
Zurück zum Zitat Cost Effective Prevention of Diabetes. World Diabetes Foundation, edited by WDF secretariat, Denmark. Annual Review, 2007. pp 30–31. Cost Effective Prevention of Diabetes. World Diabetes Foundation, edited by WDF secretariat, Denmark. Annual Review, 2007. pp 30–31.
55.
Zurück zum Zitat Willett WC, Jeffrey P, Koplan JP, Nugent R, Dusenbury C, Puska P, et al. Chap 44. Prevention of chronic disease by means of diet and lifestyle changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 833–50. doi:10.1596/978-0-821-36179-5/2006. Willett WC, Jeffrey P, Koplan JP, Nugent R, Dusenbury C, Puska P, et al. Chap 44. Prevention of chronic disease by means of diet and lifestyle changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 833–50. doi:10.​1596/​978-0-821-36179-5/​2006.​
58.
Zurück zum Zitat Rayappa PH, Raju KNM, Kapur A, Bjork S, Sylvist C, DilipKumar KM. Economic costs of diabetes the Bangalore urban district diabetes study. Int J Diab Dev Ctries 1999;19:87–96. Rayappa PH, Raju KNM, Kapur A, Bjork S, Sylvist C, DilipKumar KM. Economic costs of diabetes the Bangalore urban district diabetes study. Int J Diab Dev Ctries 1999;19:87–96.
59.
Zurück zum Zitat Global guidelines for Type-2 Diabetes, Chap1. Screening and diagnosis. International Diabetes Federation, Clinical guidelines Task Force, Brussels, 2005. Global guidelines for Type-2 Diabetes, Chap1. Screening and diagnosis. International Diabetes Federation, Clinical guidelines Task Force, Brussels, 2005.
60.
Zurück zum Zitat Narayan KMV, Zhang P, Kanaya AM, Desmond E. Williams, Engelgau M, Imperatore G, Ramachandran A. Chap-30. Diabetes: the pandemic and potential solutions. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 591–603. Narayan KMV, Zhang P, Kanaya AM, Desmond E. Williams, Engelgau M, Imperatore G, Ramachandran A. Chap-30. Diabetes: the pandemic and potential solutions. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 591–603.
Metadaten
Titel
Early diagnosis and prevention of diabetes in developing countries
verfasst von
Ramachandran Ambady
Snehalatha Chamukuttan
Publikationsdatum
01.09.2008
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 3/2008
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-008-9079-z

Weitere Artikel der Ausgabe 3/2008

Reviews in Endocrine and Metabolic Disorders 3/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.